Alpelisib
ATC L01EM03 · 10 markets · 38 records
US 11 records · 5 strengths
GB 4 records · 3 strengths
CA 4 records · 3 strengths
AU 4 records · 4 strengths
- 200 mgtabletPIQRAY alpelisib 200 mg daily dose blister (200 mg tablet)PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack
- 50 mgtabletPIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack
- 150 mgtabletPIQRAY alpelisib 200 mg daily dose blister (200 mg tablet)
Records without a stated strength · 1 PIQRAY
SG 3 records · 3 strengths
- 200 mgtabletPIQRAY 250MG DAILY DOSE PACK (200mg + 50mg)
- 50 mgtabletPIQRAY 250MG DAILY DOSE PACK (200mg + 50mg)
- 150 mgtabletPIQRAY 250MG DAILY DOSE PACK (200mg + 50mg)
ES 3 records · 3 strengths
TW 3 records · 3 strengths
HK 3 records · 1 strengths
Records without a stated strength · 1 PIQRAY
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 PIQRAY、VIJOICE
MX 1 records · 1 strengths
Records without a stated strength · 1 PIQRAY
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 200 mg tablet | Manufacturer: Novartis Pharma Stein AG ×6 PIQRAY | PIQRAY | PIQRAY | PIQRAY alpelisib 200 mg daily dose blister (200 mg tablet) PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack | PIQRAY 250MG DAILY DOSE PACK (200mg + 50mg) | PIQRAY | PIQRAY 愛克利200毫克膜衣錠 | |||
| 50 mg tablet | Manufacturer: Novartis Pharma Stein AG ×6 VIJOICE | PIQRAY Piqray 50mg tablets and Piqray 200mg tablets | PIQRAY | PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack | PIQRAY 250MG DAILY DOSE PACK (200mg + 50mg) | PIQRAY | PIQRAY 愛克利50毫克膜衣錠 | |||
| 150 mg tablet | Manufacturer: Novartis Pharma Stein AG ×6 PIQRAY | PIQRAY | PIQRAY | PIQRAY alpelisib 200 mg daily dose blister (200 mg tablet) | PIQRAY 250MG DAILY DOSE PACK (200mg + 50mg) | PIQRAY | PIQRAY 愛克利150毫克膜衣錠 | |||
| 125 mg tablet | Manufacturer: Novartis Pharma Stein AG ×6 VIJOICE | |||||||||
| 50 mg powder | VIJOICE | |||||||||
unknown | PIQRAY | PIQRAY | PIQRAY VIJOICE | |||||||
tablet | PIQRAY |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.